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■ Abstract Background Atypical depression (AD) ex-
hibits distinct patterns of gender,bipolar-II disorder,ge-
netic, and neuro-biological measures. Using prospective
data from a community sample, this paper identifies cri-
teria (and correlates) for an AD syndrome that maxi-
mizes the association with female sex and bipolar-II.
Methods The Zurich cohort study is composed of 591
subjects selected from a population-based cohort of
young adults in the canton of Zurich in Switzerland,
screened in 1978 and followed with six interviews
through 1999. Seven definitions of atypical depression
were tested, using varying combinations of vegetative
symptoms and mood reactivity. Results The atypical de-
finitions using 2 of 3 (fatigue, overeating, oversleeping)
or 2 of 2 (overeating, oversleeping) vegetative symptoms
showed the strongest association with gender, bipolar-
ity, and family history of mania. The 2/3 definition was
chosen for further analysis due to its high sensitivity for
identifying these characteristics.This syndrome had cu-
mulated weighted prevalence of 16.4 % (males 9.7 %, fe-
males 23 %); when associated with major depressive
episodes, 8.2 % (males 3.2 %, females 15.1 %). AD pa-
tients were characterized by high treatment rates, sever-
ity, and work impairment, early age of onset and long ill-
ness.AD was comorbid with social phobia, binge eating,
neurasthenia, migraine headache, and subjective cogni-
tive impairment.
■ Key words atypical depression · bipolar-II disorder ·
sex · prevalence
Introduction
The concept of atypical depression (AD) is of great in-
terest because of its association with female sex and
bipolar-II disorder. AD has been found to explain, to a
major extent, the gender difference in depression (Angst
2002) and to be a special depressive syndrome from a ge-
netic point of view (Sullivan et al. 2002; Kendler et al.
1996; Stewart et al. 1993). Recently, results from a large
multicentre sib-pairs study gave further support to the
existence of a separate atypical dimension (Korszun
et al.2004); in a factor analysis of the familiality of symp-
tom dimensions in depression, typical and reversed
neurovegetative symptoms loaded on one factor, but
gain of appetite and hypersomnia loaded negatively. A
number of neuro-biological studies found differences
between atypical and other forms of depression (Fotiou
et al. 2003; Bruder et al. 2002, 1989; Geracioti et al. 1997;
McGinn et al. 1996; Asnis et al. 1995; Quitkin et al. 1985;
Harrison et al. 1984).
In previous studies, women were reported to suffer
more often from AD than men (Benazzi 2003, 1999;
Matza et al. 2003; Angst 2002; Asnis et al. 1995; Thase
et al. 1991). At variance with these findings were some
studies restricted to reversed vegetative symptoms
(overeating, oversleeping) (Sullivan et al. 2002; Horwath
et al. 1992; Levitan et al. 1997) or on major depressive pa-
tients (Perugi et al. 1998; McGinn et al. 1996).
An association of AD with bipolar-II disorders was
observed in many studies (Angst et al. 2002; Benazzi
2001, 2000a, 2000b, 2000c), and Benazzi demonstrated
that patients with AD were often characterized by a fam-
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ily history of bipolar disorders (Benazzi 2003). Varying
definitions of AD gave varying results (Posternak and
Zimmermann 2002) and a few negative studies included
very small bipolar samples (Robertson et al. 1996; Thase
et al. 1991).
Unfortunately, great methodological difficulties bur-
den research in this field mainly in the form of varying
concepts of AD and selection of samples for studies. To
our knowledge, with the exception of the Zurich cohort
study, no other community studies assessed the full
range of atypical and typical symptoms of depression
prospectively. The Zurich study is, therefore, suitable for
multiple analyses.
The DSM-IV’s concept of atypical depression was
created by DF Klein and his group from Columbia Uni-
versity in the USA on the basis of response to
monoamine oxidase inhibitors (Sotsky and Simmens
1999; Stewart et al. 1997, 1993; Thase et al. 1991; Quitkin
et al. 1991, 1990, 1989, 1988; Davidson et al. 1988;
Liebowitz et al. 1988; Mountjoy et al. 1977; Ravaris et al.
1976; Robinson et al. 1973). The DSM-IV specifier for
atypical features requires: a) the presence of mood
reactivity, and b) two or more of the following four
symptoms: interpersonal rejection sensitivity, leaden
paralysis, significant weight gain or overeating and
oversleeping. This definition has been questioned from
several points of view. Many authors used a simpler de-
finition of atypicality including only the two neuro-veg-
etative symptoms overeating and oversleeping (Benazzi
2002a; Matza et al.2003; Sullivan et al.2002,1998; Levitan
et al. 1997; Kendler et al. 1996). Latent class analyses sup-
ported this neurovegetative concept (Sullivan et al. 1998;
Kendler et al. 1996) with the limitation that they had not
included all five criterial symptoms of atypicality and
that they did not analyse specifically bipolar-II disor-
ders. Furthermore, neurovegetative symptoms were not
found to predict treatment response (Davidson and Pel-
ton 1986). Of interest is the finding of Levitan et al.
(1997) based on a large cross-sectional community
study, that pure reversed neuro-vegetative symptoms of-
ten co-occurred over the lifetime with typical vegetative
symptoms.
Several authors raised doubts about mood reactivity
as a mandatory symptom for the diagnosis of atypical
depression (Angst et al.2002; Benazzi 2002b; Parker et al.
2002, 2000; Nierenberg et al. 1998; Perugi et al. 1998;
Rabkin et al. 1996; Thase et al. 1991). Recently, Henkel
et al. (2004) found on the basis of a configuration fre-
quency analysis of 403 primary care outpatients that
mood reactivity may also occur without any other atyp-
ical symptoms and may not be an exclusive and promi-
nent symptom of atypical depression. In our earlier pa-
per, we suggested removing the hierarchical position of
the symptom of mood reactivity (as used in the DSM-IV
definition), but keeping all five symptoms in the defini-
tion of the atypical syndrome (Angst 2002).
Apart from overeating and oversleeping, fatigue has
been stressed as an important element of AD. Himmel-
hoch and Thase (1989), Thase et al. (1989) and Thase
(1991) used the term anergic depression including fa-
tigue, motor retardation and reversed neuro-vegetative
symptoms. Silverstein et al. (1999) proposed the concept
of somatic depression characterized by fatigue, appetite
and sleep disturbance including both increased and de-
creased appetite and sleep. In this context, one has to
consider that the fatigue syndrome (neurasthenia of
ICD-10) is associated with depression.
Originally,West and Dally (1959), Sargant (1960) and
Hordern (1965) had mentioned intensive lethargy as a
core symptom of AD. Leaden paralysis in the modern
concept of AD was described and operationalized in a
key paper by Stewart et al. (1993) as the physical sensa-
tion of being “heavy, leaden, or weighted down”, having
“low physical energy”, and by questions such as “is it
ever a physical effort to climb stairs or get out of a
chair?” and “do your arms and legs sometimes feel
heavy, as though they were full of lead?”.
Recently, Parker et al. (2002) presented data suggest-
ing the existence of an atypical syndrome with the core
symptom of interpersonal rejection hypersensitivity,as-
sociated with panic disorder and social phobia, which
goes back to the origin of the concept of AD (West and
Dally 1959).
In summary, the concepts of atypical depression have
varied enormously from the inclusion of five to two
atypical symptoms. Among the five symptoms the diag-
nostic value of mood reactivity has been questioned
most and rejection oversensitivity may represent more
of a trait than a state (Angst et al. 2002).
This paper seeks to present additional data on AD
from a prospective study of a community sample fol-
lowed over 20 years, with a systematic analysis of vary-
ing definitions of the AD syndrome.The goal is the iden-
tification of a syndrome with a high correlation with
female sex and bipolar-II disorder. In addition, we will
analyse: 1) the longitudinal association and stability of
atypical and typical vegetative symptoms extending the
work of Levitan et al. (1997), 2) the suggestion of Silver-
stein et al. (1999) to include loss of appetite and insom-
nia into the vegetative symptoms, and 3) the proposal of
Parker et al. (2002) to include panic disorder and social
phobia into the concept of atypical depression.
Subjects and methods
The methodology of the Zurich study was described in this journal in
detail in an earlier paper (Angst et al. 2002), which did not yet include
the sixth wave in 1999.
■ Sample
The Zurich study comprises a sample of 4547 subjects (m = 2201;
f = 2346) representative of the canton of Zurich in Switzerland, who
were screened in 1978 with the Symptom Checklist 90-R (SCL-90-R)
(Derogatis 1977). In order to increase the probability of the develop-
ment of psychiatric syndromes, a sub-sample of 591 subjects (292
males, 299 females) was selected for interview, with two-thirds con-
sisting of high scorers (defined by the 85th percentile or more of the
SCL-90) and a random sample of those with scores below the 85th per-
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centile. The screening took place in 1978 when the male participants
were 19 and the females 20 years of age. Six interview waves were con-
ducted across 20 years from 1979 to 1999.
■ Symptoms and diagnoses
The atypical symptoms overeating,oversleeping,mood reactivity and
rejection sensitivity were assessed in the depression section of the in-
terview. Excessive physical fatigue was defined by the simultaneous
presence of depression with all of three symptoms measured in the
interview section on neurasthenia: exhaustion,somatic weakness and
extreme susceptibility to physical fatigue. This definition approxi-
mates the DSM-IV symptom of leaden paralysis without including
low energy and motor retardation.A typical vegetative syndrome was
defined by insomnia plus loss of appetite or weight assessed in the
context of the depression interview section.
Seven definitions of atypical depression (AD) were tested:
1) Three of 5 DSM-IV criterial symptoms of AD (non-hierarchical):
mood reactivity, interpersonal rejection sensitivity, leaden paral-
ysis, significant weight gain or overeating, oversleeping (Angst
et al. 2002)
2) DSM-IV AD: hierarchical, giving priority to mood reactivity
3) Two of 4 DSM-IV criterial symptoms (rejection oversensitivity,
excessive physical fatigue, overeating/weight gain, oversleeping)
4) Triadic AD (TAD): 2 of 3 criterial symptoms (excessive physical
fatigue, overeating/weight gain, oversleeping)
5) Reversed vegetative syndrome: 2 of 2 criterial symptoms (overeat-
ing/weight gain, oversleeping)
6) Two of 3 symptoms (loss of energy/excessive physical fatigue,
overeating/weight gain, oversleeping)
7) Two of 4 symptoms (loss of energy, excessive physical fatigue,
overeating/weight gain, oversleeping)
The atypical symptoms in the definitions 1–7 had to co-occur with
depressive symptoms in the last 12 months. All four interviews
1986–1999 (each covering the last 12 months) were taken into account
for the cumulative diagnoses of AD. During these years, DSM was re-
vised twice and the most recent definitions were used which could be
met by the data collected in earlier years. The diagnostic criteria for
comorbid conditions were based on DSM-III-R and DSM-IV criteria.
Classification of psychiatric disorders was made by algorithms on the
basis of DSM-III criteria (GAD, panic disorder), of DSM-III-R crite-
ria [major depressive disorder, phobias, obsessive-compulsive disor-
der (OCD)], while DSM-IV criteria were applied to substance
abuse/dependence. In order to avoid overdiagnosis of MDD, bipolar-
II disorder was diagnosed by broad criteria for hypomania as de-
scribed by Angst et al. (2003).
■ Statistics
Groups were compared by non-parametric tests (Kruskal-Wallis tests
for continuous data, χ2 tests for frequencies). Odds ratios (ORs) were
obtained by binary logistic regression.When frequencies of exposure
variables were very high or low (Table 4), the more robust risk differ-
ence (RD) was calculated in addition to the OR. The RD, also called
absolute risk reduction, is the result of subtracting the proportion of
cases in the unexposed from that in the exposed group. In multivari-
able logistic models, insignificant variables were removed from the
model one-by-one, starting with the least significant one, until a final
model was arrived at. Variables were kept in the model if their re-
moval produced large (> 20 %) changes in the coefficient of any other
variable. Given the exploratory nature of the study, we did not apply
correction for multiple comparisons.
Results
■ Criterial symptoms of atypical depression of DSM-IV
The broadest non-hierarchical definition of an atypical
depressive syndrome (Angst et al. 2002) requires the
presence of at least three of the five criterial symptoms
of DSM-IV. This classification includes DSM-IV atypical
depression as a subset.
In Table 1, the non-hierarchical atypical syndrome
among subjects with major depressive episodes (MDE)
is presented with its rates and associations of the five
1986–1999 Atypical Atypical OR (95% C.I.) p (χ2)
syndrome syndrome
No Yes
84 87
Symptoms % %
Oversleeping 38.9 89.9 14.0 (6.2–31.4) 0.0001
Overeating 22.2 54.6 4.2 (2.1–8.3) 0.0001
Excessive physical fatigue 12.5 80.8 29.5 (12.5–69.6) 0.0001
Oversensitivity 15.3 85.9 33.7 (14.3–79.2) 0.0001
Mood reactivity 80.6 90.9 2.4 (0.98–5.9) 0.05
Loss of energy 89.9 97.0 2.8 (1.02–15.6) 0.04
Syndromes
DSM-IV 0.0 83.8 n.c.
2/2 symptoms1) 4.2 42.4 16.9 (5.0–57.6) 0.0001
2/3 symptoms2) 5.6 81.8 76.5 (24.7–236.9) 0.0001
2/4 symptoms3) 12.5 100.0 n.c. (small Ns) 0.0001
2/3 symptoms + loss of energy4) 60.7 93.1 8.7 (3.4–22.3) 0.0001
2/4 symptoms + loss of energy5) 64.3 97.7 23.6 (5.4–102.8) 0.0001
1) oversleeping, overeating
2) oversleeping, overeating, excessive physical fatigue
3) oversleeping, overeating, excessive physical fatigue, oversensitivity
4) oversleeping, overeating, excessive physical fatigue/loss of energy
5) oversleeping, overeating, excessive physical fatigue, loss of energy
n.c. non-computable
Table 1 Atypical depressive syndrome (3/5 symp-
toms) in subjects with major depressive episode
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criterial symptoms cumulatively across four interviews
from 1986 to 1999 (age 28 to 41). The highest ORs were
present for the symptoms excessive physical fatigue and
rejection oversensitivity. All syndromal definitions of
atypical depression were strongly associated with the
non-hierarchical atypical syndrome.
■ Atypicality in MDD and bipolar-II disorders
Table 2 presents the distribution of the atypical symp-
toms and syndromes in subjects with major depressive
disorder (MDD) or bipolar-II (BP-II) disorder. Two
symptoms (oversleeping and excessive physical fatigue)
were or tended to be more common among BP-II than
MDD. The atypical syndromes with 2/2 and 2/3 symp-
toms showed the strongest associations with bipolarity.
The analogue definitions including loss of energy
showed no significant association with BP-II disorders.
■ Atypicality and sex
With the exception of mood reactivity, all atypical
symptoms were significantly more common among fe-
males than males.An elevated sex ratio (OR) in favour of
females was found for all definitions of an atypical syn-
drome (Table 3).
■ Atypicality and family history of mania
In Table 4, the associations of the five atypical symptoms
with a family history of mania are given. None of the
symptoms was significantly associated with a positive
family history of mania; excessive physical fatigue and
rejection oversensitivity showed a mild trend (p < 0.09).
In contrast to these results, significant associations
were found for atypical syndromes defined by 2/2
(OR = 3.0) and 2/3 atypical symptoms (OR = 3.9). The
inclusion of loss of energy as a further symptom gave
non-significant results.
■ Cumulative associations and stability 
of vegetative syndromes
Vegetative syndromes associated 
with depressive symptoms
Cumulatively across four interviews from age 28 to 41,
atypical (reversed) vegetative syndrome (hypersomnia,
increase of appetite or weight) was only in 14 (20 %) of
68 cases associated with the typical vegetative syndrome
defined by insomnia and loss of appetite or loss of
weight (p < 0.46).
The triadic atypical depressive syndrome (with or
without major depression) was in 47 (34.8 %) of 135
cases associated with the typical vegetative syndrome
(p < 0.04); similarly, the DSM-IV atypical depressive
syndrome was in 30 (36.1 %) of 83 cases associated with
the typical vegetative syndrome (p < 0.02).
Vegetative syndromes associated with MDE
In contrast to the previous significant findings, on the
restricted diagnostic level of MDE, there were no signif-
icant associations present: triadic atypical depression
1986–1999 MDD BP II OR (95% C.I.) p (χ2)
88 83
Syndromes % %
Oversleeping 62.5 74.7 1.8 (0.9–3.4) 0.086
Overeating 35.2 47.0 1.6 (0.9–3.0) 0.118
Excessive physical fatigue 44.3 60.2 1.9 (1.0–3.5) 0.04
Oversensitivity 54.6 57.8 1.1 (0.6–2.1) 0.67
Mood reactivity 85.2 88.0 1.3 (0.5–3.1) 0.60
Loss of energy and drive 94.3 92.8 0.8 (0.2–2.6) 0.68
Syndromes
DSM-IV 46.6 50.6 1.2 (0.6–2.1) 0.5999
2/2 symptoms1) 17.1 36.1 2.8 (1.3–5.6) 0.0046
2/3 symptoms2) 42.1 57.8 2.4 (1.3–4.5) 0.0391
2/4 symptoms3) 56.8 69.9 1.8 (0.98–3.3) 0.0768
3/5 symptoms4) 51.1 65.1 1.8 (0.96–3.3) 0.0653
2/3 symptoms + loss of energy5) 75.0 79.5 1.3 (0.6–2.7) 0.4816
2/4 symptoms + loss of energy6) 79.5 83.1 1.3 (0.6–2.7) 0.5478
1) oversleeping, overeating
2) oversleeping, overeating, excessive physical fatigue
3) oversleeping, overeating, excessive physical fatigue, oversensitivity
4) oversleeping, overeating, excessive physical fatigue, oversensitivity, mood reactivity
5) oversleeping, overeating, excessive physical fatigue/loss of energy
6) oversleeping, overeating, excessive physical fatigue, loss of energy
Table 2 Bipolar II vs. major depressive disorders
(MDD): atypical depressive symptoms
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was in 27 (35.1 %) of 77 cases associated with typical
vegetative syndromes (p < 0.90), whereas DSM-IV atyp-
ical depression was in 47 (36.5 %) of 77 cases associated
with typical vegetative syndromes (p < 0.82).
Temporal stability of vegetative syndromes
Associated with depressive symptoms atypical (N = 45)
and typical (N = 61) vegetative syndromes were in only
one-third of cases stable across at least two of the four
interviews (31 % and 34 %, respectively).
1986–1999 Men Women OR (95% C.I.) p (χ2)
175 203
Symptoms % %
Oversleeping 50.9 64.5 1.8 (1.2–2.7) 0.007
Overeating 26.9 40.4 1.8 (1.2–2.9) 0.006
Excessive physical fatigue 27.4 47.3 2.4 (0.5–3.7) 0.000
Oversensitivity 33.1 49.3 2.0 (1.3–3.0) 0.002
Mood reactivity 89.1 91.6 1.3 (0.7–2.7) 0.412
Loss of energy 86.7 95.6 3.3 (1.5–7.3) 0.002
Syndromes
DSM-IV definition 29.7 46.8 2.1 (1.4–3.2) 0.0007
2/2 symptoms1) 12.0 26.1 2.6 (1.5–4.5) 0.0006
2/3 symptoms2) 24.0 45.8 2.7 (1.7–4.2) 0.0001
2/4 symptoms3) 37.7 56.7 2.2 (1.4–3.3) 0.0001
3/5 symptoms4) 35.4 51.7 2.0 (1.3–3.0) 0.0015
2/3 symptoms + loss of energy5) 66.2 84.0 2.7 (1.3–5.6) 0.0071
2/4 symptoms + loss of energy6) 72.1 86.8 2.5 (1.2–5.5) 0.0184
1) oversleeping, overeating
2) oversleeping, overeating, excessive physical fatigue
3) oversleeping, overeating, excessive physical fatigue, oversensitivity
4) oversleeping, overeating, excessive physical fatigue, oversensitivity, mood reactivity
5) oversleeping, overeating, excessive physical fatigue/loss of energy
6) oversleeping, overeating, excessive physical fatigue, loss of energy
Table 3 Sex and atypical depressive syndromes
FH mania FH mania OR Risk p
negative positive (95% C.I.) difference
N row % row % unadjusted
Symptoms
Oversleeping 116 90.1 9.9 1.6 (0.8–3.1) 0.17 0.19
Overeating 68 89.5 10.5 1.5 (0.7–3.1) 0.10 0.26
Excessive physical fatigue 89 88.7 11.3 1.8 (0.9–3.6) 0.19 0.09
Oversensitivity 93 90.1 9.9 1.8 (0.9–3.5) 0.25 0.09
Mood reactivity 145 92.6 7.4 0.7 (0.4–1.5) –0.10 0.37
Loss of energy and drive 157 91.1 8.9 n.c. 0.004 0.35
Syndromes
DSM-IV 82 89.0 11.0 1.9 (0.6–6.1) 0.16 0.2443
2/2 symptoms1) 45 84.4 15.6 3.0 (0.99–9.1) 0.25 0.0440
2/3 symptoms2) 85 87.1 12.9 3.9 (1.0–14.4) 0.30 0.0323
2/4 symptoms3) 108 8.7 1.3 3.7 (0.8–17.1) 0.24 0.0752
3/5 symptoms4) 98 88.8 11.2 2.7 (0.7–10.2) 0.21 0.1204
2/3 symptoms + loss of energy5) 129 90.7 9.3 1.8 (0.4–8.4) 0.09 0.4521
2/4 symptoms + loss of energy6) 136 91.2 8.8 1.4 (0.3–6.4) 0.04 0.7004
1) oversleeping, overeating
2) oversleeping, overeating, excessive physical fatigue
3) oversleeping, overeating, excessive physical fatigue, oversensitivity
4) oversleeping, overeating, excessive physical fatigue, oversensitivity, mood reactivity
5) oversleeping, overeating, excessive physical fatigue/loss of energy
6) oversleeping, overeating, excessive physical fatigue, loss of energy
n.c. non-computable
Table 4 Family history (FH) of mania
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■ Multivariable models of varying definitions 
of atypicality
In the next step, we analysed the associations of four de-
finitions of atypical syndromes (selected based on the
results of Tables 2 and 4) with variables often reported in
the literature as being characteristic for atypical depres-
sion: sex,BP-II vs.MDD,and a positive family history for
mania. These characteristics were used as dependent
variables in multivariable logistic regressions. The dif-
ferent definitions of atypicality were included as predic-
tor variables. Additionally, BP-II was included as a pre-
dictor in the model for sex and sex was included as a
predictor in the models for BP-II and family history of
mania. Table 5 shows that the only significant predictor
for female sex was the 2/3 definition, while the only sig-
nificant predictor for BP-II (vs. MDD) was the 2/2 defin-
ition. In the model for family history, the 2/2 and 2/3 de-
finition remained as final predictors, but both were
non-significant. Both were kept, because removing any
one of them produced large changes in the coefficient of
the remaining variable, indicating an interference.
■ Sensitivity and specificity
The 2/3 definition had higher sensitivity for identifying
women (45.8 %), BP-II cases (57.8 %) and cases with a
positive family history of mania (57.1 %) than the 2/2
definition (26.1, 36.1 and 39.3 %, respectively). In con-
trast, the 2/2 had higher specificity than the 2/3 defini-
tion (88.0, 83.0 and 81.2 % vs. 76, 58.0 and 64.6 %).
On the basis of these results, we chose the triadic
atypical depression syndrome defined by the presence
of two of the three symptoms oversleeping, overeating
and excessive physical fatigue for further analyses. This
syndrome had a cumulative weighted prevalence rate of
16.4 % (males 9.7 %, females 23 %). When associated
with major depressive episodes (including BP-II and
MDD), the prevalence rate was 8.2 % (males 3.2 %, fe-
males 15.1 %). Bipolar II had a weighted prevalence rate
of 4.6 % of atypical depression and 6.9 % of non-atypical
depression; major depressive disorder consisted of 3.6 %
atypical and 9.1 % non-atypical depression (Table 8). As
a consequence, 40 % of BP-II depression and 28.3 % of
major depressive disorders were atypical.
■ Bipolar-II and major depressive disorders
subclassified by triadic atypical depression
Tables 6–8 compare depressive and cognitive symptoms,
clinical characteristics and comorbidity of atypical vs.
non-atypical BP-II and MDD.We have to distinguish be-
tween significant differences as a consequence of
BP/MDD differences and those due to atypicality.
In addition to the criterial symptoms for atypicality
(increased appetite, weight gain, hypersomnia), most
symptoms of depression occurred more frequently
among atypical than non-atypical cases (Table 6). The
most significant were loss of energy, irritability, inhibi-
tion, reduced sexual desire, self blame, hopelessness and
fear of everyday tasks.
The typical vegetative symptoms of depression, in-
somnia and loss of appetite, were not associated with
atypicality (Table 6). Of the 171 subjects with MDE, 45
manifested reversed and 61 typical vegetative syn-
dromes.Among the 171 subjects with MDE,there was no
significant association between typical and reversed
vegetative symptoms (OR = 0.8 (0.4–1.6), p < 0.46). Of
the 45 subjects (31.1 %) with major depressive episodes,
14 manifested both reversed and typical vegetative
symptoms over the four interviews.
To our surprise, symptom scores of subjective cogni-
tive impairment (poor concentration, impaired mem-
ory, distractibility) were significantly higher in atypical
than non-atypical mood disorder (Table 7). The mean of
the three cognitive symptoms in atypical cases was sig-
nificantly higher for atypical [2.8 (s. d. = 0.52)] than for
non-atypical cases [2.2 (s. d. = 0.83)] (p < 0.0001). The
association of subjective cognitive impairment with
atypical depression was independent of the definition of
atypicality. For instance, the subjective cognitive im-
pairment in subjects with DSM-IV atypical depression
was higher [2.76 (s. d. = 0.83)] than in subjects with non-
atypical depression [2.27 (s. d. = 0.58)] (p < 0.0000). In
the case of reversed neuro-vegetative symptoms, the re-
spective cognitive impairment scores were 2.81
(s. d. = 0.52) for atypical vs. 2.21 (s. d. = 0.52) (p < 0.0000)
for non-atypical cases.
Uni- and bipolar disorders did not differ significantly
in their cognitive impairment scores (2.48 vs. 2.54,
p < 0.23).
As Table 8 shows, patients with triadic atypical syn-
dromes were characterized by higher rates of females,
earlier age of onset, higher rates of a family history for
mania, longer illness, and higher treatment rates and
Dependent variable Predictor variables
Sex Sampling 2/2 definition 2/3 definition 2/4 definition 3/5 definition BP-II
(Female) sex – – 2.7 (1.7–4.2) – – –
BP-II – – 2.8 (1.3–5.6) – – –
FH + mania – – 2.0 (0.6–6.0) 1.6 (0.5–4.8) – –
’–‘ Indicates variable not in final model; black cells indicate variable not included in initial model
Table 5 Multivariable logistic regres-
sion models for the validators sex, BP-II
and family history of mania: Odds Ratios
and 95% confidence intervals
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severity (measured by the total number of the nine cri-
terial symptoms for MDE and by the number of axis I di-
agnoses) and higher rates of work impairment. Com-
pared to patients without TAD, the course of patients
with TAD was significantly more severe in terms of %
years of observation of depressive symptoms and treat-
ment. TAD was comorbid to a significant extent with so-
cial phobia,binge eating and neurasthenia.Of special in-
terest was the association of migraine with atypical
depression, in contrast to tension headache which was
not associated; tension headache was more often found
among bipolar than unipolar depressive disorder
(MDD). There was no association of atypicality with
body mass index (BMI).
■ Are DSM-IV atypical symptoms associated with panic
disorder and social phobia (Parker 2002)?
In order to analyse the questions of Parker et al. (2002)
regarding an association of panic disorder and social
phobia with the five DSM-IV symptoms of atypical de-
Table 6 Symptoms of triadic atypical and other depression
BP-II MDD
Atypical Non-atypical Atypical Non-atypical p (all) p (atypical vs. OR (95% C.I.)
N 41 35 37 51 non-atypical) (atypical vs. non-atypical)
Symptoms % % % %
Worse in the morning 60.4 37.1 54.1 31.4 0.0149 0.002 2.7 (1.4–5.1)
Cries easily 70.8 62.9 86.5 60.8 0.0539 0.032 1.6 (0.8–3.4)
Irritable 93.8 80.0 97.3 80.4 0.0262 0.002 9.5 (2.0–44.7)
Loss of appetite 66.7 57.1 54.1 60.8 0.6673 0.802 0.9 (0.5–1.8)
Increased appetite 64.6 14.3 51.4 17.7 0.0001 0.0001 8.1 (3.7–18.0)
Weight loss 47.9 17.1 37.8 47.1 0.0183 0.247 1.2 (0.6–2.3)
Weight gain 43.8 8.6 43.2 10.2 0.0001 0.0001 6.8 (2.8–16.2)
Inhibited 95.8 65.7 75.7 72.6 0.0044 0.006 2.5 (1.1–5.8)
Insomnia 66.7 57.1 78.4 60.8 0.2282 0.087 1.5 (0.8–3.0)
Hypersomnia 95.8 42.9 89.2 41.2 0.0001 0.0001 16.5 (6.4–42.7)
Loss of energy 100.0 82.9 97.3 92.2 0.0118 0.005 8.9 (1.1–73.7)
Social withdrawal 93.8 77.1 89.2 84.3 0.1551 0.047 2.5 (0.9–6.7)
Motor retardation 68.8 48.8 46.0 33.3 0.0055 0.012 2.1 (1.1–3.9)
Restless, agitated 70.8 48.6 56.8 49.0 0.1081 0.036 1.8 (0.9–3.4)
Loss of interest 97.9 88.6 94.6 84.3 0.0872 0.016 3.9 (1.0–15.1)
Reduced sexual desire 87.5 62.9 86.5 68.6 0.0135 0.001 2.6 (1.1–5.8)
Low self esteem 87.5 68.6 83.8 74.5 0.1384 0.027 1.6 (0.7–3.7)
Self blame 91.7 62.9 78.4 54.9 0.0003 0.0001 4.2 (1.9–9.1)
Hopeless 81.3 60.0 91.9 60.8 0.0016 0.0001 3.6 (1.6–8.3)
Fear of everyday tasks 68.8 28.6 48.7 27.5 0.0001 0.0001 3.1 (1.6–6.0)
BP-II MDD
Atypical Non-atypical Atypical Non-atypical p (all) p (atypical vs.
N 48 35 37 51 non-atypical)
Symptoms % % % %
Indecisive 97.2 62.9 89.2 74.5 0.0001 0.000
Poor concentration 97.9 77.1 94.6 90.2 0.011 0.009
Impaired memory 91.7 68.6 89.2 64.7 0.002 0.000
N of cognitive symptoms 0.000 0.000
0 0.0 5.7 2.7 2.0
1 2.1 17.1 2.7 13.7
2 8.3 40 13.5 37.3
3 89.6 37.1 81.1 47.1
Mean (s.d.) 2.9 (0.4) 2.1 (0.9) 2.7 (0.7) 2.3 (0.8) 0.0001 0.0001
N cognitive symptoms
SCL-90-R
Mean (s.d.) 1.3 (0.7) 0.7 (0.5) 1.1 (0.8) 0.7 (0.6) 0.001 0.0001
N cognitive symptoms
(1978–1999)
Table 7 Cognitive symptoms in bipolar
and unipolar triadic atypical depression
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pression, we carried out multivariable logistic regres-
sions, using the five symptoms as dependent variables
and entering sex, stratified sampling, bipolar-II disor-
der, panic disorder and social phobia as independent
variables.
Social phobia was significantly associated with ex-
cessive physical fatigue, almost significantly (p < 0.06)
with overeating, and not associated with mood reactiv-
ity, rejection oversensitivity and oversleeping. Panic dis-
order was not significantly associated with any atypical
symptom.
Discussion
The analytic strategy of this paper was chosen on the ba-
sis of reports from the literature, summarized in the in-
troduction, which demonstrated a strong association of
Table 8 Clinical characteristics and comorbidity of subtypes of mood disorders
Bipolar-II MDD
Atypical Non-atypical Atypical Non-atypical p (all) p (atypical vs. OR (95% C.I.)
N 48 35 37 51 non-atypical) (atypical vs.
non-atypical)
Prevalence rate (%) 4.6 6.9 3.6 9.1 – – –
Men (% weighted) 2.4 7.6 0.8 7.7 – – –
Women (% weighted) 6.9 6.2 6.4 10.5 – – –
Women (%) 68.8 42.9 75.7 58.8 0.023 0.009 2.3 (1.2–4.4)
Age of onset (years) of sx 13.3 (4.6) 14.6 (5.0) 11.8 (4.9) 15.4 (5.7) 0.005 0.0008 0.9 (0.9–1.0)
Number of depressive sx (mean, s.d.) 8.2 (0.9) 7.0 (1.1) 7.9 (1.0) 7.3 (1.3) 0.055 0.0016 2.0 (1.5–2.7)
Distress (0–100) (mean, s.d.) 86.0 (14.5) 82.1 (16.5) 80.5 (17.4) 85.6 (13.1) 0.325 0.94 1.0 (0.98–1.01)
Mean (s.d.) % years suffered from depressive sx 66.7 (19.5) 54.2 (19.8) 65.7 (23.5) 47.8 (24.3) 0.0001 0.0001 1.03 (1.02–1.05)
Work impairment (%) 97.9 82.9 91.9 92.2 0.106 0.099 2.7 (0.8–8.9)
Treated (%) 83.3 60.0 64.9 49.0 0.005 0.003 2.7 (1.4–5.1)
Mean (s.d.) % years treated 19.7 (20.7) 9.6 (11.5) 12.1 (15.0) 11.0 (19.7) 0.006 0.004
Hospitalized depression (%) 12.5 8.6 8.1 3.9 0.488 0.255 1.9 (0.6–6.0)
Suicide attempts (%) 33.3 25.7 27.0 21.6 0.621 0.280 1.5 (0.7–2.9)
FH + for mania (%) 22.9 2.9 0.0 4.4 0.0001 0.032 3.9 (1.0–14.4)
FH + for depression (%) 66.7 60.0 62.2 72.9 0.607 0.705 0.9 (0.5–1.7)
Ups and downs (%) 41.7 37.1 27.0 17.7 0.051 0.167 1.6 (0.8–3.1)
Comorbidity
General anxiety disorder 47.9 31.4 24.3 35.3 0.139 0.592 1.2 (0.6–2.2)
Repeated panic attacks 41.7 31.4 37.8 27.5 0.468 0.133 1.6 (0.9–3.1)
Agoraphobia 20.8 11.4 16.2 7.8 0.284 0.073 2.3 (0.9–5.6)
Social phobia 31.3 14.3 35.1 13.7 0.032 0.003 3.0 (1.4–6.5)
Specific phobia 25.0 20.0 27.0 17.7 0.699 0.252 1.5 (0.7–3.2)
Obsessive-compulsive disorder 14.6 2.9 5.4 7.8 0.229 0.255 1.9 (0.6–6.0)
Obsessive-compulsive syndrome 39.6 17.1 24.3 25.5 0.128 0.112 1.7 (0.9–3.4)
Bulimia 6.3 0.0 8.1 2.0 0.243 0.052 6.5 (0.8–54.8)
Binge eating 31.3 11.4 18.9 11.8 0.050 0.017 2.7 (1.2–6.0)
BMI (mean, s.d.) 24.0 (4.3) 23.6 (3.3) 24.0 (5.6) 23.1 (3.4) 0.80 0.91 1.03 (0.97–1.11)
Neurasthenia 37.5 11.4 40.5 13.7 0.002 0.0001 4.3 (2.0–9.3)
Tobacco dependence 60.4 60.0 48.7 47.1 0.438 0.697 1.1 (0.6–2.1)
Alcohol abuse/dependence 43.8 51.4 13.5 21.6 0.001 0.661 0.9 (0.5–1.6)
Cannabis weekly 22.9 17.1 13.5 13.7 0.593 0.518 1.3 (0.6–2.9)
Sedatives weekly 12.5 5.7 10.8 7.8 0.720 0.282 1.8 (0.6–5.1)
Stimulant abuse/dependence 16.7 5.7 5.4 3.9 0.090 0.090 2.7 (0.8–9.1)
Substance abuse/dependence1) 56.3 60.0 27.0 31.4 0.003 0.947 1.0 (0.6–1.9)
Migraine IHS2) 14.9 8.6 30.6 18.4 0.099 0.213 1.7 (0.7–3.7)
Migraine broad definition 52.1 37.1 67.6 39.2 0.027 0.007 2.3 (1.2–4.2)
Tension headache 42.6 48.6 13.9 32.7 0.011 0.214 0.7 (0.4–1.3)
Mean (s.d.) number of axis I diagnoses 4.5 (2.2) 3.5 (1.6) 3.8 (1.9) 3.1 (1.6) 0.03 0.02 1.3 (1.1–1.5)
(including tobacco abuse) median: 4 median: 3 median: 3 median: 3
Mean (s.d.) number of axis I diagnoses 3.9 (2.2) 2.9 (1.4) 3.3 (1.8) 2.6 (1.3) 0.03 0.008 1.4 (1.1–1.6)
(excluding tobacco abuse) median: 3 median: 3 median: 3 median: 2
1) Without tobacco; 2) International Headache Society
sx symptoms
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atypical depression with female sex and bipolar-II dis-
order. Tentatively, our goal was to identify a syndrome of
atypical depression, derived from the five criterial
symptoms of DSM-IV, which would discriminate best
between the sexes and between bipolar II and major de-
pressive disorders. As a further validator, a family his-
tory of mania was used in multivariable logistic regres-
sions controlling for sex and stratified sampling. This
strategy cannot validate a concept by treatment re-
sponse to MAOI, which was a reason for the creation of
the atypical concept.
The analysis of the five criterial symptoms of atypi-
cal depression (DSM-IV) confirmed that mood reactiv-
ity was an unspecific symptom of depression (Korszun
et al. 2004). There was a trend to an association with the
non-hierarchically defined atypical depressive syn-
drome (ADS) (taking into account all five symptoms),
but mood reactivity was not associated with a family
history of mania or with bipolar disorder. As a conse-
quence of the latter finding and due to the hierarchical
position of mood reactivity for the DSM-IV diagnosis of
depression, the same is also true on the diagnostic level.
Rejection oversensitivity was strongly associated
with the ADS and was, therefore, analysed as part of an
atypical syndrome defined by 2 of 4 symptoms. This
syndrome was associated with female sex and margin-
ally with bipolar disorder and a family history of mania,
but an even stronger association with sex and bipolarity
was found for the reversed vegetative syndrome (2 of 2
symptoms) and a slightly broader definition including
also excessive physical fatigue (2 of 3 symptoms = TAD).
Our community data indicate the advantages of using
a triadic concept of atypical depression (TAD) defined
by the presence of two of the following three symptoms:
excessive physical fatigue, overeating, oversleeping. In
contrast to the definition restricted to reversed vegeta-
tive symptoms, the broader concept of TAD is more sen-
sitive without losing its validity in terms of our goal.Our
definition of TAD is close to the concept of Silverstein
et al. (1999) of a somatic depression with physical fa-
tigue and two vegetative symptoms, but Silverstein et
al.’s proposal to include also typical vegetative symp-
toms was not supported by our data. Further analyses
will have to follow on the concept of somatic depression.
Loss of drive and energy are intuitively symptoms as-
sociated with fatigue and lethargy,which are elements of
the symptom leaden paralysis.Tentatively,we added loss
of drive or energy as a fourth symptom to the three that
define TAD. The analyses showed no significant rela-
tionship with bipolar-II disorder and with a family his-
tory of mania; there was no trend to a better validity of
this syndrome. The inclusion within the symptoms of
excessive physical fatigue was also negative in its valid-
ity. Loss of drive and energy is probably an unspecific
and characteristic symptom of depression in general, as
suggested by the analysis of Korszun et al. (2004).
On the basis of the analyses on sensitivity and speci-
ficity for sex differences, we chose as most suitable the
TAD definition. This is in line with the literature which
shows a good agreement regarding the over-representa-
tion of atypicality among females, whereas a special cor-
relation with bipolar disorder has been controversial, as
mentioned in the introduction.
Weighted for stratified sampling, TAD was observed
more often in depressed women (44 %) than men (17 %)
and in bipolar-II disorder (40 %) than in major depres-
sive disorders (28.3 %). The weighted prevalence rate of
major triadic atypical depression (TAD) was 8.2 %, 4.6 %
for bipolar-II and 3.6 % for MDD. The difference be-
tween atypical bipolar-II and MDD is small, but adds to
the controversial findings reported in the literature.
Among the depressive symptoms associated with
TAD, subjective cognitive impairment (reduced mem-
ory, concentration and decision-making) was most re-
markable. The majority of subjects with major TAD
(85.9 %) complained about all three cognitive symp-
toms, whereas this was the case in 43 % of non-atypical
MDE. The high rate of reported cognitive impairment in
subjects with atypical depression seems to be a new
finding, independent of the definition of atypical de-
pression and worth being clarified by proper neuropsy-
chological testing.
Also of interest is the association of TAD with social
phobia, supporting Parker et al.’s findings (2002), as well
as the association with migraine but not with tension
headache. Migraine was not significantly associated
with major depressive episodes or bipolar-II disorder as
usually described in the literature, but it was associated
with AD, which is more common in women as migraine
is.
The association of TAD with binge eating and
neurasthenia is not surprising, because there is some
conceptual overlap on the symptom level (overeating,
physical fatigue).
Across four interviews from age 26 to 41, we found an
instability of the vegetative symptoms; one-third of pa-
tients with reversed vegetative syndromes manifested
longitudinally also a typical vegetative syndrome (loss
of appetite/weight and insomnia). This is in agreement
with the observations in a community sample investi-
gated by Levitan et al. (1997), who described a subgroup
manifesting longitudinally both reversed and typical
vegetative symptoms.
■ Limitations
The results are based on a relatively small sample from
the community although, if weighted for stratified sam-
pling, it represents 2600 subjects. Type II errors cannot
be excluded in cases of negative results in small cell oc-
cupations. The results certainly need confirmation by
other larger studies, especially in clinical samples. Fur-
ther studies will have to test whether the new definition
of an atypical depressive syndrome is of greater validity
and utility than other definitions. The findings on cog-
nition need specific neuro-psychological testing.
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